One population of T-lymphocytes upregulated during the stable phase in ALS mice (Beers et al, 2011a) and which could be involved in slowing disease progression of ALS patients are CD4+CD25HighFoxP3+ regulatory T-lymphocytes (Tregs). The gene discussed is CD4; the disease is amyotrophic lateral sclerosis.